Point-of-Care Molecular Diagnostics Market
完整報告名稱與涵蓋範圍
Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report, By Product (Cartridge-Based Molecular Analyzers, Rapid Isothermal and CRISPR-Based Test Systems, Test Cartridges, Assays and Consumables, Connectivity Software and Data Management), By Application (Respiratory Infections (Influenza, RSV, SARS-CoV-2 and Multiplex Panels), Sexually Transmitted Infections and Women's Health, Hospital-Acquired Infections and Antimicrobial Resistance, Tuberculosis and Global Health Applications), By End User (Hospitals, Emergency Departments and Intensive Care Units, Physician Offices and Urgent Care Clinics, Pharmacies and Retail Clinics, Community Health and Low-Resource Settings), By Region, and Segment Forecasts, 2026-2035
報告摘要
The point-of-care molecular diagnostics market covers cartridge-based analyzers, rapid isothermal and CRISPR-based test systems, assays and consumables and connectivity software that deliver nucleic acid test results at or near the patient in hospitals, physician offices, pharmacies and community settings. Central laboratory molecular diagnostics are covered in the broader InsightAce molecular diagnostics study; antigen and lateral flow tests are excluded.
Decentralised molecular testing expanded dramatically during the pandemic and has retained a larger footprint as clinicians and patients expect laboratory-quality answers within an hour for respiratory infections, sexually transmitted infections and hospital-acquired pathogens. Growth is driven by waived-test regulatory status that allows testing outside laboratories, by pharmacy test-and-treat models, by antimicrobial stewardship that depends on rapid pathogen identification and by global health programs deploying molecular platforms for tuberculosis and HIV. Manufacturers are broadening menus on installed analyzers, reducing cost per test, developing single-use instrument-free devices and connecting results to electronic records and public health surveillance, while reimbursement, instrument placement economics and competition from multiplex central laboratory panels shape adoption.
North America leads through waived-test volumes and pharmacy channels, Europe follows, and India, Africa and Southeast Asia represent large global health deployments alongside growing private demand. Competition involves molecular diagnostics leaders with installed analyzer bases, rapid test innovators, Indian and Chinese platform manufacturers and pharmacy and retail partners.
The InsightAce study delivers revenue forecasts in US$ across all product, application and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Point-of-Care Molecular Diagnostics Market Snapshot
Chapter 4. Global Point-of-Care Molecular Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. Product & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product:
5.2.1. Cartridge-Based Molecular Analyzers
5.2.2. Rapid Isothermal and CRISPR-Based Test Systems
5.2.3. Test Cartridges, Assays and Consumables
5.2.4. Connectivity Software and Data Management
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. Application & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Application:
6.2.1. Respiratory Infections (Influenza, RSV, SARS-CoV-2 and Multiplex Panels)
6.2.2. Sexually Transmitted Infections and Women's Health
6.2.3. Hospital-Acquired Infections and Antimicrobial Resistance
6.2.4. Tuberculosis and Global Health Applications
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. End User & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
7.2.1. Hospitals, Emergency Departments and Intensive Care Units
7.2.2. Physician Offices and Urgent Care Clinics
7.2.3. Pharmacies and Retail Clinics
7.2.4. Community Health and Low-Resource Settings
Chapter 8. Point-of-Care Molecular Diagnostics Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Danaher Corporation (Cepheid)
10.2. Abbott Laboratories
10.3. bioMerieux SA
10.4. Roche Holding AG
10.5. QuidelOrtho Corporation
10.6. Visby Medical, Inc.
10.7. binx health, Inc.
10.8. SD Biosensor, Inc.
10.9. Sherlock Biosciences, Inc.
10.10. Lucira Health (Pfizer Inc.)
10.11. Talis Biomedical Corporation
10.12. Molbio Diagnostics Pvt. Ltd.
10.13. Cue Health Legacy Platforms
10.14. LumiraDx (Roche)
10.15. Ustar Biotechnologies (Hangzhou) Ltd.
圖表清單 List of Tables & Figures
Table 1. Global Point-of-Care Molecular Diagnostics Market Revenue Forecast by Product, 2026-2035 (US$ Mn)
Figure 1. Global Point-of-Care Molecular Diagnostics Market Segmentation Overview
Table 2. Global Point-of-Care Molecular Diagnostics Market Revenue Forecast by Application, 2026-2035 (US$ Mn)
Figure 2. Global Point-of-Care Molecular Diagnostics Market Share by Product, 2026 & 2035
Table 3. Global Point-of-Care Molecular Diagnostics Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 3. Decentralised Molecular Testing Footprint by Setting and Regulatory Status, 2026-2035
Table 4. North America Point-of-Care Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 4. Global Point-of-Care Molecular Diagnostics Market Share by Application, 2026 & 2035
Table 5. Europe Point-of-Care Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Installed Analyzer Base and Test Menu Expansion Strategies by Manufacturer
Table 6. Asia Pacific Point-of-Care Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Point-of-Care Molecular Diagnostics Growth Opportunity Analysis
Table 7. Latin America Point-of-Care Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Pharmacy Test-and-Treat and Antimicrobial Stewardship Drivers of Rapid Molecular Adoption
Table 8. Middle East & Africa Point-of-Care Molecular Diagnostics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Point-of-Care Molecular Diagnostics Market Participants
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們